Janumet FDA Approval History
FDA Approved: Yes (First approved March 30, 2007)
Brand name: Janumet
Generic name: metformin and sitagliptin
Dosage form: Tablets
Company: Merck & Co., Inc.
Treatment for: Diabetes, Type 2
Janumet is a combination of the oral antihyperglycemic drugs sitagliptin and metformin indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus.
Development Timeline for Janumet
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.